$PRTA

Walker Karin L sold (to issuer) $128K of PRTA

Walker Karin L (Chief Accounting Officer) sold (to issuer) 15,000 shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $8.56 ($0.13M total) on 2026-07-28.

Original reporting
SEC EDGAR · Walker Karin L
Published Jul 31, 2026, 12:34 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 1:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PRTA
Neutral
high confidence
Mentioned
$PRTA
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PRTANeutralLow
01

Why it matters

The disclosure updates insider ownership but does not include any new corporate event, guidance, or material development for PRTA.

02

Market read

Traders may note insider activity, but the filing alone is unlikely to change PRTA valuation expectations.

03

What to watch

Insider sales to the issuer can be administrative (e.g., buyback participation) and may not reflect a directional view on PRTA fundamentals.

Relevance 4/10Novelty 2/10Timing: Filed 2026-07-30 for a 2026-07-28 transaction.

Background

SEC Form 4 insider transaction for Prothena Corp Public Ltd Co (PRTA) by CFO Walker Karin L.

Company-level read

Ticker impact

$PRTANeutralHigh confidence
Context

Prothena (PRTA) disclosed a Form 4 sale to the issuer by CFO Walker Karin L of 15,000 shares at $8.56 on 2026-07-28.

Expected impact

Limited near-term impact; any effect is likely noise versus normal trading.

Evidence & confidence

The filing is an insider sale to the issuer, with no 10b5-1 plan and no accompanying company guidance, deal, or regulatory action in the text.

Market effects

No clear sector read-through from a single insider sale to the issuer.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan could be interpreted as discretionary selling, but the article provides no rationale or follow-on signals.

Key entities

  • PROTHENA CORP PUBLIC LTD CO

    Company subject of the Form 4 insider transaction disclosure.

  • Walker Karin L

    Chief Accounting Officer who sold 15,000 shares to the issuer at $8.56 on 2026-07-28.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PRTAMed

PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus

Prothena (PRTA) reported Q2 2026 adjusted loss per share of 32 cents, narrower than the Zacks estimate of a 39-cent loss. Revenues were $1.01 million versus $4.4 million a year earlier, mainly collaboration revenue from Bristol Myers Squibb (BMY) for PRX019. Prothena had $330.3 million cash, no debt, and reaffirmed 2026 net cash use guidance of $18-$23 million.

$PRTAMed

Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

PROTHENA CORP PUBLIC LTD CO (PRTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PRESS RELEASE Prothena Reports Second Quarter 2026 Financial Results an d Business Highlights • Net cash used in operating and investing activities was $25.7 million in the second quarter, and net cash provided by operating and investing activities was $3.2 million f

$COURMedAI 8/10

Pale Fire Capital SE (Senkypl Dusan, Barta Jan) purchased $11.4M of COUR (indirect holdings)

Pale Fire Capital SE purchased 2,332,742 indirectly-held shares of Coursera, Inc. (COUR) at an average of $4.87 ($4.61–$5.06, $11.36M total) across 2 trades over 2026-09-25 to 2026-09-29. Filed jointly with Pale Fire Capital SICAV a.s. (10% owner), Pale Fire Capital investicni spolecnost a.s. (10% owner), Senkypl Dusan (10% owner) and Barta Jan (10% owner).